Trades on 2 secondary markets

Arrakis Therapeutics

Arrakis Therapeutics is a clinical-stage biopharmaceutical company pioneering RNA-targeted small molecules (rSMs) — orally available small-molecule medicines designed to bind directly to RNA and reach targets long considered undruggable. Its rSM Platform and rSM Toolkit industrialize the discovery a

minimal 8.8 / 100 0 APIs View provider profile →

Company Biotechnology Pharmaceutical RNA Drug Discovery Genetic Medicine

Arrakis Therapeutics is an API provider whose private shares are listed on 2 secondary markets: Forge Global, Nasdaq Private Market.

Where It Trades

F Forge Global View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.